ArticleHepatology communications2022

Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.

Noreen Nog-Qin Chui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.